España se sitúa como el cuarto país en inversión total en sanidad pública en Europa, con 134 mil millones de euros, superada solo por Alemania (489 mil millones), Francia (313 mil millones) e Ita...
The round was led by London-based VC Concentric, with participation from Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg, known for backing 1...
Since its launch in 2015, the ”la Caixa” Foundation has allocated €24.8 million to support the transfer of scientific knowledge to the market through CaixaImpulse, which supports health innovati...
The company previously closed a €650,000 pre-seed round in April 2023 through Capital Cell, complemented by an ENISA participatory loan and NextGeneration-EU grants, reaching a total accumulated fun...
The funds will be used to incorporate new advances into the FiCAT gene writing platform, validate various next generation CAR-T therapies in the preclinical phase and expand the FiCAT cell engineering...
The financing was led by SV Health Investors’ Dementia Discovery Fund, joined by a syndicate of leading international life science venture investors: British Business Bank, M Ventures, Novartis Vent...
Gyala Therapeutics is a biotechnology company focused on developing next-generation immunotherapies to treat hematological cancers with unmet medical needs. Its lead program is GYA01, a first-in-class...
Founded in 2021 as a spin-off of Pompeu Fabra University, KOA Biotech was born with the mission of revolutionizing aquaculture through cutting-edge technology. The company is transforming health manag...
FreeOx has developed the first cerebroprotective therapy designed to preserve the brain during acute ischemic stroke. It is the key piece in stroke treatment, as it focuses on microcirculation and sol...
After years of research, the company presents its saliva-based test for the early detection of head and neck cancer, capable of delivering results in less than 24 hours with nearly 100% reliability
BStartup was supported by professional advisors such as SILO and specialized VC funds including Columbus Venture Partners, Asabys, and Alta Life Sciences, backing the potential of the project. In this...
The European Commission and the European Investment Bank (EIB) Group have announced an initiative to mobilise €10 billion in investment in 2026-27 into the biotech and life sciences sector. The proj...